Utilising Human Primary Immunodeficiencies To Study Lymphocyte Differentiation
Funder
National Health and Medical Research Council
Funding Amount
$429,346.00
Summary
Human immunodeficiencies are diseases arising from naturally occurring mutations. In this instance, the specific genes mutated in the immunodeficiencies we study have been identified. However, it is unclear how defects in these genes make an individual manifest as an immune deficient state, rendering them vulnerable to disease. By studying immune cells from these individuals we hope to uncover the normal function of these genes and subsequently provide for new therapies for these conditions.
Control Of T Helper Cells In Autoimmunity And Anti-tumour Responses.
Funder
National Health and Medical Research Council
Funding Amount
$434,953.00
Summary
The proposed studies aim to improve our understanding of the factors that regulate a specialised immune cell type called “T helper” cells and their function in models of autoimmune disease and during anti-tumour immune responses. The project will investigate (1) the role of a signalling protein called Interleukin 27 in these processes and (2) how several novel genes, recently found to be associated with the development of MS in humans, influence T helper cell activity.
Importance Of Functional Antibodies Against Infectious Diseases
Funder
National Health and Medical Research Council
Funding Amount
$431,000.00
Summary
Antibodies are highly functional proteins capable of recognizing infectious disease pathogens and instructing surrounding immune cells to attack them. This project aims to identify specific antibody targets on HIV and Mycobacterium Tuberculosis associated with protection/control of disease and to understand the mechanisms behind the most functional antibodies. Ultimately, these studies will guide the development of future vaccines and therapies against these deadly pathogens.